Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Flunarizine for Treatment Resistant Absence Epilepsy

NCT06153186 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT06153186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06153186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Flunarizine for Treatment Resistant Absence Epilepsy
Lead sponsor
University of British Columbia
Phase
Phase 2
Overall status
Terminated
Start date
September 20, 2019
Completion date
May 26, 2023
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

childhood absence epilepsy, juvenile absence epilepsy, juvenile myoclonic epilepsy